Drug resistance continues to limit the long-term benefit of many targeted therapies and chemotherapies against cancer. While “classical” small-molecule ...

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma ...

This Research Topic is part of a series with:<br/><a href=" Discoveries and Pharmaceutical Development in Urologic Tumors<br/><br/>Urologic tumors encompass cancers of the prostate, bladder, kidney, ...

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth. Lung cancer, specifically Non-Small Cell Lung Cancer (NSCLC)-the most common ...

The Government has clarified that all oncology medicines are covered under the Drugs (Prices Control) Order, 2013 (DPCO, 2013 ...